(Q46554336)

23 December 2017

title

Successful use of sirolimus in a patient with bulky ovarian metastasis of hepatocellular carcinoma after liver transplantation (English)

1 reference

23 December 2017

1 reference

liver transplantation

1 reference

based on heuristic

inferred from title

hepatocellular carcinoma

1 reference

1 reference

1 reference

1

1 reference

23 December 2017

author name string

Kasper HU

2

1 reference

23 December 2017

Schleimer K

3

1 reference

23 December 2017

Töx U

4

1 reference

23 December 2017

Bangard C

5

1 reference

23 December 2017

Hölscher AH

6

1 reference

23 December 2017

Beckurts KT

7

1 reference

23 December 2017

language of work or name

English

0 references

publication date

1 June 2005

1 reference

23 December 2017

Transplantation Proceedings

published in

1 reference

23 December 2017

volume

37

1 reference

23 December 2017

issue

5

1 reference

23 December 2017

page(s)

2185-2187

1 reference

23 December 2017

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.03.013

Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.03.013

Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.03.013

Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.03.013

Sirolimus inhibits growth of human hepatoma cells in contrast to tacrolimus which promotes cell growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.03.013

Sirolimus for pediatric liver transplant recipients with post-transplant lymphoproliferative disease and hepatoblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.03.013

Sirolimus as primary immunosuppression in liver transplantation is not associated with hepatic artery or wound complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.03.013

Rapamycin: friend, foe, or misunderstood?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.03.013

Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. The Cancer of the Liver Italian Program (CLIP) Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.03.013

Massive solitary metastasis of hepatocellular carcinoma in the ovary two years after liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.03.013

Withdrawal of immunosuppression in liver transplantation: lessons learned from PTLD

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.03.013

Rapamycin protects allografts from rejection while simultaneously attacking tumors in immunosuppressed mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2005.03.013

10.1016/J.TRANSPROCEED.2005.03.013

7 January 2021

Identifiers

DOI

1 reference

23 December 2017

PubMed ID

15964374

1 reference

23 December 2017